cardiology grand rounds - minneapolis heart institute...
TRANSCRIPT
PLEASE SAVE A COPY OF THIS FLIER AS YOUR CERTIFICATE OF ATTENDANCE
C A R D I O L O G Y G R A N D R O U N D S Presentation: Use of CT to support appropriate selection of patients and devices
/ guide to non‐surgical mitral valve replacement
Speaker: Jonathon A. Leipsic, MD, FRCPS, FSCCTChairman, Department of Radiology, Providence Health Care, Vancouver, BC Vice Chairman – Research, University of British Columbia, Department of Radiology Associate Professor of Radiology and Cardiology, University of British Columbia Canada Research Chair, Advanced Cardiopulmonary Imaging
Date: Monday, October 26, 2015, 7:00 – 8:00 AM
Location: ANW Education Building, Watson Room
OBJECTIVES At the completion of this activity, the participants should be able to: 1. Review the role of MDCT for structural heart disease and transcatheter valvular assessment. 2. Review the current data for the use of MDCT for mitral valvular assessment and annular sizing for TMVI. 3. Discuss the unanswered questions that remain in transcatheter mitral valve implantation and how MDCT may
provide some answers.
ACCREDITATION Physicians: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Allina Health and Minneapolis Heart Institute Foundation. Allina Health is accredited by the ACCME to provide continuing medical education for physicians.
Allina Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nurses: This activity has been designed to meet the Minnesota Board of Nursing continuing education requirements for 1.2 hours of credit. However, the nurse is responsible for determining whether this activity meets the requirements for acceptable continuing education.
Others: Individuals representing other professional disciplines may submit course materials to their respective professional associations for 1.0 hours of continuing education credit.
DISCLOSURE STATEMENTS Speaker(s): Dr. Leipsic has declared following relationships. Consultant: Neovasc Inc. and Tendyne Holdings Inc.
Planning Committee: Dr. Michael Miedema, and Eva Zewdie have declared that they do not have any conflicts of interest associated with the planning of this activity. Dr. Robert Schwartz declared the following relationships ‐ stockholder: Cardiomind, Interface Biologics, Aritech, DSI/Transoma, InstyMeds, Intervalve, Medtronic, Osprey Medical, Stout Medical, Tricardia LLC, CoAptus Inc, Augustine Biomedical; scientific advisory board: Abbott Laboratories, Boston Scientific, MEDRAD Inc, Thomas, McNerney & Partners, Cardiomind, Interface Biologics; options: BackBeat Medical, BioHeart, CHF Solutions; speakers bureau: Vital Images; consultant: Edwards LifeSciences.
11/2/2015
1
MDCT to Guide Mitral Valve Interventions
Jonathon Leipsic MD FRCPC FSCCTVice Chairman of Radiology
Associate Professor Radiology and Cardiology UBC
President Society of Cardiovascular CTCanada Research Chair Advanced Cardiac
Imaging
Disclosures
Speaker’s bureau: GE Healthcare and Edwards LifeSciences
Grant Support‐ CIHR, NIH, GE Healthcare, Heartflow
Consultant‐Heartflow,
Edwards LifeSciences, Neovasc, Circle CVI
Corelab‐ NIH, Edwards Lifesciences, Neovasc, Tendyne
11/2/2015
2
Learning Lessons from TAVI
The Virtual Basal Ring
Source: Leipsic et al JACC Img April 2011
Sinotubular junctionAortic leafletsAortic Annulus
Aortic Annular Diameter
RC = Right coronary cusp; NC = Non-coronary cusp; LC = Left coronary cusp
11/2/2015
3
Live Case Summary‐TCT
• 89 year old female
• Severe degenerative mitral regurgitation
• NYHA III
• Coronary artery bypass grafting ‐ 2008
• Chronic kidney disease ‐ eGFR 40mL/min
• Chronic bronchitis/COPD
• 6 minute walk test – 340m
• STS – 16.1%
Neovasc Tiara Transcatheter Mitral Valve• Anatomically shaped (D‐shaped)
• Nitinol based, self‐expanding frame
• Bovine pericardium leaflets
• Ventricular anchors to fix the valve onto fibrous trigone and posterior annulus
• Captures the anterior and posterior leaflets
11/2/2015
4
Annular Segmentation
Angle Prediction and coronary sinus localization
11/2/2015
5
Device Cloning and Neo LVOT
How did we get to this point together?
11/2/2015
6
1‐MDCT aids in the diagnosis of valvular disease
Temporal Resolution
• Echo > 30 fps (<33 msec)
• 64‐slice CT 165 msec
• Dual‐source CT 83 msec (2nd Gen. 75msec)
CT Limitations Assessing Valves
11/2/2015
7
CT Limitations Assessing Valves
• Irregular rhythms (variability, gating)
• Difficult images and artifacts
–Obesity
–Calcium and leads
–Motion artifacts
Strength of CT is Anatomical DetailUnicuspid Valve Quadricuspid
11/2/2015
8
Normal Mitral Valve Anatomy on MDCT
Mitral Valvular Disease
• Patient with rheumatic mitral valve and mild mitral stenosis (valve area 1.6 cm2)
11/2/2015
9
Mitral valve stenosis‐ Limited Data
Planimetry by CT vs. Echocardiography
Messika-Zeitoun et al. JACC 2006
Moderate Mitral Stenosis
11/2/2015
10
Mitral Regurgitation
MR can be isolated in location (involved
scallops) or timing (part of systole)
Minimum Intensity Projection
Any MR? Moderate MR by TEE
11/2/2015
11
• Most common valvular heart disease
Classification
• due to a primary abnormality of the valve apparatus
– Mitral valve prolapse (aka "degenerative" or myxomatousmitral valve disease)
– Rheumatic heart disease
– Infective endocarditis
• secondary to another cardiac disease (functional)
– Ischemic cardiomyopathy
– Dilated cardiomyopathies
Mitral regurgitationFacts
• abnormal systolic displacement of one or both leaflets into the left atrium (systolic billowing) due to a disruption or elongation of leaflets, chordae, or papillary muscles
• Echocardiography: Billowing of any portion of the mitral leaflets ≥2 mm above the annular plane in a long axis view (parasternal or apical three‐chamber)
Mitral Valve Prolapse (MVP)
Definition
Classification
•abnormal movement of the valve: • Billowing: when the tips of leaflets remain in the left ventricle• Flail: when the tip(s) of one (or both) leaflets prolapses into the left atrium
11/2/2015
12
Mitral Valve Prolapse (MVP)
Ethiology of MVP and mechanism of MR
Disease Mechanism of regurgitation
Primary MVP
Fibroelastic deficiencyIsolated prolapse of the mitral leaflet (commonly P2 scallop)Frequent chordal ruptureMild annular enlargement
Forme fruste Barlow disease Intermediate
Barlow diseaseDiffusely thickened, redundant mitral leafletsChordal elongation/ruptureSevere annular enlargement
Secondary MVP
Associated with connective tissue disease*
Diffusely thickened, redundant mitral leafletsChordal elongation/ruptureSevere annular enlargement
Associated with congenital heart disease
¶Thickened, redundant mitral leafletsChordal elongation/rupture possible
Acute myocardial ischemia Papillary muscle dysfunction with secondary prolapse/papillary muscle rupture
Acute rheumatic fever Chordal and leaflet destruction by acute inflammatory process
Endocarditis Chordal and leaflet destruction by infectious process; vegetations
Other (trauma, severe mitralannular calcification, hypertrophic
cardiomyopathy)Ruptured chordae, no myxomatous changes of mitral valve leaflets
Image: Adams et al. EHJ 2010 Table: Uptodate.com
Mitral valve apparatusLeaflet anatomy
MPR minIP
11/2/2015
13
Mitral valve apparatusPapillary muscles
Mitral Valve Prolapse
11/2/2015
14
Mitral Valve Prolapse
Mitral Valve Prolapse (MVP)
Importance of the employed view
MVP should never be diagnosed on 4 chamber reconstruction
11/2/2015
15
Mitral Valve Prolapse (MVP)
Importance of the employed view
https://depts.washington.edu/cvrtc/iafnew.gifLevine et al. Circulation 1989
Mitral Valve Prolapse (MVP)
Pseudoprolapse
11/2/2015
16
Diagnostic Accuracy of MDCT for MVP
Source: Feuchtner et al Radiology 2010
4 ways CT can help with TMVI in 2015
• Anatomic assessment of valvular apparatus
• Help with annular sizing and device selection
• Understanding mechanisms and risk of LVOT obstruction
• Prediction of appropriate fluoroscopy angles for coaxial deployment
11/2/2015
17
2‐MDCT allows for a granular and clear definition of the mitral
annulus
MDCT to Guide TranscatheterMitral Valve Replacement
11/2/2015
18
Advantages to MDCT methods
Greater reproducibility (less operator dependent)
Less sensitive to minor changes in obliquity
“3‐D”“3‐D”
“2D”Source: Gurvitch et al JACC Interventions Nov 2011
Mitral Annulus is non‐planar
Source: Levine et al Circulation 1989
Saddle shape with a valley and 2 peaks extending to the aortic root
11/2/2015
19
The mitral annulus is segmented posteriorly along the insertion of the posteriormitral valve leaflet and anteriorly along the insertion of the intervalvular fibrosa.
Mitral Annular Segmentation with MDCT
Source: Blanke et al. JACC Imaging 2015
Segmentation of the Saddle and D Shaped Annulus
Source: Blanke and Naoum et al JACC Imaging 2015
11/2/2015
20
Saddle Shaped Annulus
Mitral annulus
• Posterior peak: Insertion of the posterior mitralleaflet at atrioventricularjunction
• Anterior/aortic peak:insertion of intervalvularfibrosa at the left atrium, in part continuous with the aortic annulus
• Nadirs: are located at the level of fibrous trigones.
Lee et al. Circulation 2013
Flachskampf et al. Circulation 2000
The mitral annulus is segmented posteriorly along the insertion of the posteriormitral valve leaflet and anteriorly along the insertion of the intervalvular fibrosa.
Mitral Annular Segmentation with MDCT
Source: Blanke et al. JACC Imaging 2015
11/2/2015
21
Mitral annulusCT segmentation ‐ Saddle‐shaped annulus
Saddled Annulus
Projected area
Traditional Method for Mitral Annular Assessment
11/2/2015
22
Mitral Annulus in the context of TMVI
Projected area
Source: Blanke et al JCCT 2014 and iJACC Imaging 2015
Re‐thinking the Mitral Annulus
11/2/2015
23
“unsaddled” annulus
TT
“unsaddled” annulus
TT
11/2/2015
24
Conformational similarities with an implanted device in vivo
Source: Cheung et al. JACC 2014
Aortic Annulus is Dynamic
Source: Blanke et al JACC Int ; Leipsic et al Circ Imaging Jun 2013
11/2/2015
25
Dynamic Changes of the Aortic Annulus
CT for Valvular Heart Disease
CT……..
Atrial kick
LV largest
EarlyS
EndS
11/2/2015
26
Mitral Annulus is also Dynamic
Source: Unpublished data
3‐Different devices with different designs have different anatomical requirements
Tiara Fortis Tendyne
Source: Cheung et al JACC 2014; Bapat Euroint 2014; Moat et al JACC 2015
11/2/2015
27
Different devices with different designs
Source: In press Blanke et al JACC Imaging
Confirmation of Mitral Valve Prolapse
11/2/2015
28
Anatomical assessment of device anchoring by MDCT
Device anchoring
Sufficient posterior shelfin the setting of dilatedLV, persisting in diastoleand systole
Sufficient posterior shelf in the setting of a focal basal scar and dilated LV, persisting in diastole and systole
Landing zone differs among mitral pathologies and patients
LV
LA
MAd
MA disjuction
LV
LA
LV
LA
LV
LA
LA
LV
myocardialshelf
LA
LV
myocardialshelf
A
D
B
E
C
F
Landing Zone Characterization
MA disjuction
11/2/2015
29
Landing Zone CharacterizationMitral annular calcium
3‐Co‐planar angle prediction with MDCT
11/2/2015
30
Fluoroscopy angulation predictionLine of perpendicularity
Identificationof annulus
plane
Adjusting toLAO 0˚
Adjusting toCAU 0˚
Adjusting toLAO 30˚
1 2 3
1 2 3 Blanke, Leipsic Radiology 2013
MDCT vs 3‐D Angio CT for Angle Prediction
Source: Binder et al. TCT 2011 , Circ Interventions April 2012
11/2/2015
31
Not all preferred projections are feasible
Prediction of fluoroscopy angulation
• Corresponding LAO/RAO and CRA/CAU
Variable projections for different devices
11/2/2015
32
Coronary sinus segmentation to aid with deployment
Simulation of the coronary sinus wire (yellow line) and mitral annular plane in “compromise views” in
two different patients.
Only some angles are feasible in the hybrid OR
11/2/2015
33
Clinical Implications for TMVI
Source: in press JCCT
4‐ Prediction of LVOT Obstruction
11/2/2015
34
Predisposing factors for LVOT obstruction
Small LVOT‐diameter
Septal bulge
Larger Aorto‐mitral angle
Device protrusion into LV
Device flaring
Remaining systolic function
Mechanisms of LVOT Obstruction‐ Concept of the Neo‐LVOT
11/2/2015
35
Concept of the Neo‐LVOT
Mechanisms of LVOT Obstruction
11/2/2015
36
Implications for Sizing and LVOT Clearance
Source: Blanke et al JACC Imaging
Modeling the risk of LVOT Obstruction‐
Need dynamic data to more deeply understand individual risk
11/2/2015
37
Determination of LVOT Clearance
Important lessons from post implant CT to understand device positioning and capture
Learning from post‐implant geometry
11/2/2015
38
Modeling the risk of LVOT Obstruction‐
Need dynamic data to more deeply understand individual risk
Mechanism of LVOT Obstruction in native Transcatheter Mitral Valve Implantation
11/2/2015
39
5‐ Aids in access localization to guide co‐planar device deployment
Source: Blanke et al JACC Imaging 2015
Historical approach for TA procedures may not be adequate in TMVI
11/2/2015
40
Echo views: Purple line rotational axis through apex, blue line ideal access trajectory
3CH‐View Dependent x‐plane90degrees
Plane through ideal access point
Blue line indicates view above
14mm Antero‐lateral
Varied offset of Optimal access point and traditional apex
11/2/2015
41
Whole thorax allows localization of the appropriate rib space for puncture
11/2/2015
42
Expanding to the Tricuspid Space
Clinical Experience to date
• 13 patients (Canada and Switzerland)
• Prohibitive risk for cardiac surgery per heart team (compassionate use)
• Left sided disease with secondary RV dilation
• Severe functional TR
11/2/2015
43
Edwards FORMA Repair System
FORMA System consists of:1. Spacer
– Positioned into the regurgitant orifice
– Creates a platform for native leaflet coaptation
2. Rail
– Tracks Spacer into position
– Distally and proximally anchored
Echo Confirmation of Severe TR
• Dilated annulus (>>40 mm)
• Dilated right atrium
• Leaflet mal‐coaptation
11/2/2015
44
Echo Confirmation of Severe TR
Echo Confirmation of Severe TR
Vena contracta
11/2/2015
45
Pre‐procedural Evaluation I
• Short axis view
• Large centralgap
Pre‐procedural Evaluation I
• Annular area = 20 cm2
• 15 mm Spacer area = 1.76 cm2
• Very low risk of Stenosis
11/2/2015
46
RAO42 CAU2
Co‐planar angle prediction with MDCT
Localization of the cardiac apex
APEX projects anteriorto Trans‐section point with myocardium
11/2/2015
47
Orthogonal view LA048 CAU2
APEX
4 chamber view
11/2/2015
48
Surgical Cut‐Down
Subclavian Vein
24 F Sheath in Left Subclavian Vein
Anchoring of the Delivery Rail
11/2/2015
49
Anchoring of the Delivery Rail
Spacer Positioning in the Tricuspid Valve
Initial position Final position
11/2/2015
50
Intra‐procedural reduction of TR severity
Before spacer After spacer
Proximal locking and Closure
Proximal part of the delivery rail is coiled and secured in a subcutaneous pocket
11/2/2015
51
Final location of FORMA spacerin the Tricuspid Valve
Systole Diastole
Valve leaflet
Anchor
SpacerRail
A
B
Using CT to understand device positioning
11/2/2015
52
Conclusions
• Rapid evolution of transcatheter solutions for functional mitral regurgitation
• Role of MDCT is evolving particularly with regards to Transcatheter Mitral Valve Replacement
• Outcomes data is needed to better optimize the integration of MDCT to guide minimally invasive mitral valve interventions
• Continued learning to integrate MDCT into right sided valvular disease